David P. Meeker, Executive VP, Chief Operating Officer at GENZYME CORP (GENZ), sold 2,732 shares at $45.60 ($125K) on 2010-05-25, disclosed to the SEC on 2010-05-26.
Open-market sale of $125k GENZ by Executive VP, Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |